Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit

/PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the "Group" or "Sirnaomics"), a leading...

Related Keywords

China ,Boston ,Massachusetts ,United States ,Germantown ,Richardw Welch ,Patrick Lu ,Group Or Sirnaomics ,Sirnaomics Ltd ,Stock Code ,Chief Executive ,Vice President ,Based Therapeutic ,Polypeptide Nanoparticle ,Cancer Therapeutics ,Squamous Cell Carcinoma ,Basal Cell Carcinoma ,Key Clinical Study Readouts ,Developing Robust Processes ,Enable Large Scale Manufacturing ,Scaling Novel ,Based Therapeutics Summit ,Sirnaomics ,